Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Alnylam Pharmaceuticals, Inc. (ALNY) - free report >>
ICL Group Ltd. (ICL) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alnylam Pharmaceuticals, Inc. (ALNY) - free report >>
ICL Group Ltd. (ICL) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 21st
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
CareDx, Inc (CDNA - Free Report) : This diagnostic solutions company for transplant patients and caregivers has seen the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
CareDx, Inc. Price and Consensus
CareDx, Inc. price-consensus-chart | CareDx, Inc. Quote
Alnylam Pharmaceuticals, Inc. (ALNY - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.
Alnylam Pharmaceuticals, Inc. Price and Consensus
Alnylam Pharmaceuticals, Inc. price-consensus-chart | Alnylam Pharmaceuticals, Inc. Quote
ICL Group Ltd (ICL - Free Report) : This specialty minerals and chemicals company has seen the Zacks Consensus Estimate for its next year earnings increasing 8.8% over the last 60 days.
ICL Group Ltd. Price and Consensus
ICL Group Ltd. price-consensus-chart | ICL Group Ltd. Quote
Anavex Life Sciences Corp. (AVXL - Free Report) : This clinical stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.
Anavex Life Sciences Corp. Price and Consensus
Anavex Life Sciences Corp. price-consensus-chart | Anavex Life Sciences Corp. Quote
Alcoa Corporation (AA - Free Report) : This company that produces and sells bauxite, alumina, and aluminum products has seen the Zacks Consensus Estimate for its current year earnings increasing 21.4% over the last 60 days.
Alcoa Price and Consensus
Alcoa price-consensus-chart | Alcoa Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.